Antonio Lanzone

Antonio Lanzone

Auto-generated profile, based on publicly available information

Antonio Lanzone

Department of Woman′s and Child′s Health, Obstetrics Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CTChiara Tersigni
Chiara Tersigni
FMFederica Meli
Federica Meli
CNCaterina Neri
Caterina Neri
AIAzzurra Iacoangeli
Azzurra Iacoangeli
RFRita Franco
Rita Franco
Nicoletta Di SimoneNicoletta Di Simone
Nicoletta Di Simone
The successful maternal tolerance of the semi-allogeneic fetus provides an apparent immunologic paradox. Indeed, deep invasion of placental trophoblast cells into maternal uterine tissue and the following growth of the fetus have to be tolerated by a pregnant woman’s immune system. Among the various possible protective mechanisms that may be involved in human pregnancy, the expression of a non-classical pattern of human leukocyte antigen (HLA) class I molecules and the complete lack of expression of HLA class II molecules in placental tissues seem to be the most relevant mechanisms of fetal escape from maternal immune recognition. The importance of HLA molecules in fetal toleration by the maternal immune system is highlighted by pregnancy complications occurring in cases of abnormal HLA molecule expression at the maternal–fetal interface. In this review, we summarize evidences about the role of placental HLA molecules in normal and pathological pregnancies.

Federica PerelliFederica Perelli
Federica Perelli
ITirene Turrini
irene Turrini
MGMaria Gabriella Giorgi
Maria Gabriella Giorgi
IRIrene Renda
Irene Renda
AVAnnalisa Vidiri
Annalisa Vidiri
ACAnna Franca Cavaliere
Anna Franca Cavaliere
Many clinical conditions require radiological diagnostic exams based on the emission of different kinds of energy and the use of contrast agents, such as computerized tomography (CT), positron emission tomography (PET), magnetic resonance (MR), ultrasound (US), and X-ray imaging. Pregnant patients who should be submitted for diagnostic examinations with contrast agents represent a group of patients with whom it is necessary to consider both maternal and fetal effects. Radiological examinations use different types of contrast media, the most used and studied are represented by iodinate contrast agents, gadolinium, fluorodeoxyglucose, gastrographin, bariumsulfate, and nanobubbles used in contrast-enhanced ultrasound (CEUS). The present paper reports the available data about each contrast agent and its effect related to the mother and fetus. This review aims to clarify the clinical practices to follow in cases where a radiodiagnostic examination with a contrast medium is indicated to be performed on a pregnant patient.

11 January 2022 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Danilo BuonsensoDanilo Buonsenso
Danilo Buonsenso
Simonetta CostaSimonetta Costa
Simonetta Costa
LGLucia Giordano
Lucia Giordano
FPFrancesca Priolo
Francesca Priolo
ACArianna Turriziani Colonna
Arianna Turriziani Colonna
PVpiero valentini
piero valentini
The long-term outcomes of newborns exposed to SARS-CoV-2 infection in utero or during the first hours of life are still unknown. We performed a single-center, prospective, observational study of newborns born from mothers with microbiologically confirmed SARS-CoV-2 infection in pregnancy or at time of delivery. Infants were offered a multidisciplinary follow-up consisting of nasopharyngeal Polymerase Chain Reaction test at birth and at 48–72 h of life, auxological growth and neurological development, serologic testing, and audiological and ophthalmological assessments. One-hundred ninety-eight mothers and 199 newborns were enrolled. Of the 199 newborns, 171 underwent nasopharyngeal swab, four (2.3%) and two (1.15%) children tested positive at birth and 48–72 h of life, respectively. None had SARS-CoV-2 related symptoms. Auxologic and neurologic development were normal in all children during follow-up. Nine out of 59 infants had SARS-CoV-2 IgG at 3 months of life, which was associated with a positive nasopharyngeal swab at birth (P = 0.04). Twenty seven out of 143 (18.8%) newborns had pathologic transitory evoked otoacoustic emissions at birth, although 14/27 repeated after 1 month were normal. Audiological evaluation was completed with Auditory Brainstem Response between the third and sixth month of life in 34 children, showing in all normal hearing threshold. The ophthalmological evaluation found retinal vascular anomalies in 3/20 (15%) children, immature visual acuity in 5/20 (25%) children, and reduced distance attention in 6/20 cases (30%). Conclusions: Our study showed that the neonatal and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 infection in utero or during the first hours of life are mostly positive, with the exception of ophthalmologic findings which, in a preliminary cohort, were abnormal in about 15% of cases. Further prospective, longitudinal studies are needed to better understand the clinical outcomes of children exposed to SARS-CoV-2 in utero and in the early postnatal life. What is Known: • In utero mother-to-child transmission of SARS-CoV-2 has been documented by several independent studies. • Neonatal COVID-19 is a systemic disease that can be severe, although rarely. What is New: • Newborns exposed in utero to SARS-CoV-2 have mostly a normal auxological, audiological, and neurological development during the first months of life. • Fundus fluorescein angiography revealed that up to 5% of newborns exposed in utero to SARS-CoV2 can show retinal and choroidal abnormalities, including peripheral hypofluorescence of the choroid and increased vascular tortuosity.

17 September 2020 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
CTChiara Tersigni
Chiara Tersigni
CNCaterina Neri
Caterina Neri
SILVIA D'IPPOLITOSILVIA D'IPPOLITO
SILVIA D'IPPOLITO
SGSerafina Garofalo
Serafina Garofalo
CMCarmelinda Martino
Carmelinda Martino
Nicoletta Di SimoneNicoletta Di Simone
Nicoletta Di Simone
Preterm delivery (PTD) represents the leading cause of neonatal death and disability. Among risk factors for PTD, maternal obesity (MO) is becoming an ever more relevant condition in developed coun...

23 August 2021 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
LTlinda tartaglione
linda tartaglione
ESEnrico Di Stasio
Enrico Di Stasio
ASAngelo Sirico
Angelo Sirico
MLMauro Di Leo
Mauro Di Leo
SCSalvatore Caputo
Salvatore Caputo
ALAntonio Lanzone
Antonio Lanzone
Continuous glucose monitoring (CGM) might be an effective tool to improve glycemic control in gestational diabetes mellitus (GDM). Few data are available about its utilization as a diagnostic tool to find potential alterations of glycemia in subjects with normal oral glucose tolerance test (OGTT). In this preliminary prospective real-life observational study, we aimed to analyze the glycemic pattern in normal and gestational diabetes mellitus (GDM) women by continuous glucose monitoring (CGM) in order to detect potential differences between the two groups and glycemic alterations despite a normal OGTT. After the screening for GDM, subjects were connected to a CGM system for seven consecutive days. The areas under the curve of the first 60 minutes after each meal and 60 minutes before breakfast were analyzed. Women with normal OGTT that during CGM showed impaired glycemic values (more than 95 fasting or more than 140 one hour after meals or more than 120 two hours after meals) performed one week of self-monitoring of blood glucose (SMBG). After OGTT, 53 women considered normal and 46 affected by GDM were included. CGM parameters did not show any differences between the two groups with impaired glycemic excursions found in both groups. After CGM period, 33 women with normal OGTT showed abnormal glycemic patterns. These 33 women then performed one week of SMBG. After evaluation of one week of SMBG, 21 required diet therapy and 12 required insulin treatment and were followed until the delivery. An increase in gestational weight gain was observed in normal women with normal OGTT but this was not significant. No significant data were found regarding neonatal outcomes in the two groups of women. In conclusion, CGM use in pregnancy might help to detect glycemic fluctuations in women with normal OGTT, improving their treatment and outcomes.

25 March 2019 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
ESE. Scarinci
E. Scarinci
ATA. Tropea
A. Tropea
GNG. Notaristefano
G. Notaristefano
Vincenzo ArenaVincenzo Arena
Vincenzo Arena
OAO. Alesiani
O. Alesiani
RAR. Apa
R. Apa